News

Roche and InterMune have announced dosing of first patient in a phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS

Mylan has reported that the company and its subsidiary, Mylan Pharmaceuticals has filed a civil lawsuit in the Circuit Court of Monongalia County, WVa, against the Pittsburgh Post-Gazette,

Bayer Schering has submitted an application for registration of a new formulation of Levitra (vardenafil HCI) in the EU. The company claims that in contrast to other drugs

Merck has reported that the US District Court for the District of New Jersey has ruled in it’s favor in a patent infringement suit against Teva. Teva was

Keith Houlihan, president and chief executive officer of Sanomedics International, has announced the launch of Sanomedics Development Corporation. The new corporation will be led by Abhishek Shrivastava, chief

Samples will be sent from SRL’s territories to Rosetta Genomics’ Philadelphia-based CLIA-certified laboratory for analysis. The terms of the deal were not disclosed. SRL will distribute miRview mets,

Peplin has completed the enrolment in second phase 3 clinical trial for the use of PEP005 (ingenol mebutate) Gel to treat actinic (solar) keratoses (AK), on non-head treatment

FDA has licensed the CSL Biotherapies’ (CSL) newest vaccine filling and packaging facility, located in Kankakee, Illinois. The facility, part of an investment to expand CSL’s US influenza

FDA has accepted the new drug application (NDA) from Strativa Pharmaceuticals, the proprietary products division of a wholly-owned subsidiary of Par Pharmaceutical, for miconazole Lauriad mucoadhesive buccal tablets